Many Active Pharmaceutical Ingredients (API) such as the antiviral agent famciclovir (FCV) are required for paediatric treatment but are not commercially available in age-appropriate dosage forms. It is common practice to prepare oral liquid dosage forms using commercially available tablets, capsules or powdered API and then dispersing or dissolving the crushed and/or powdered materials in a vehicle that the patient can swallow. Vehicles that are commonly used for this purpose include methylcellulose, syrup or combinations of these carriers where possible or commercially available suspending agents such as Ora-Sweet®, if available, can be used. However, several critical factors are overlooked when manufacturing extemporaneous formulations including, but not limited to, physical and chemical properties of the API, excipients, compatibility, stability and bioavailability issues. A stability-indicating High Performance Liquid Chromatography (HPLC) method for the analysis of FCV was developed and validated according to the International Conference on Harmonization (ICH) guidelines. The method is sensitive, selective, precise, accurate and linear over the concentration range 2-120 μg/ml. The stability of 25 mg/ml FCV formulations was assessed in vehicles manufactured from syrup simplex, hydroxypropyl methylcellulose (HPMC), Ora-Sweet® and an aqueous buffer (pH 6) following storage at 25 °C/60% RH and 40 °C/75% RH over six (6) to eight (8) weeks. The shelf life of the products was calculated as the longest period of storage for approximately 90% of the added FCV to be recovered. Formulations were manufactured using syrup simplex or HPMC with methylparaben and propylparaben individually or in combination and with sodium metabisulphite, ascorbic acid or citric acid as antioxidants. The resultant products were subject to quality control analysis for API content, viscosity, pH and appearance and the resultant data were subject to statistical analysis. The degradation rates were calculated for each product and a degradation profile plotted. The degradation rates of FCV in extemporaneous formulations were compared to those of FCV manufactured using a commercially available suspending agent and a buffered vehicle. FCV undergoes major degradation in the presence of sucrose, as observed for formulations in which the vehicle was syrup and Ora-Sweet®. FCV was found to be most stable when dissolved/dispersed in an HPMC vehicle incorporating sodium metabisulphite and a combination of parabens. The formulation that exhibited the maximum stability was manufactured using an aqueous solution buffered to pH 6. Due to the enhanced stability of FCV when added to a buffered vehicle a formulation in which an HPMC vehicle buffered to pH 6 with sodium metabisulphite, methylparaben and propylparaben was selected for optimisation using a Central Composite Design approach (CCD). In this way it was possible to establish a relationship between input variables such as pH, % w/v HPMC, % w/v antioxidant and % w/v preservative and the responses selected for monitoring by means of response surface modelling. A quadratic model was found to be the most appropriate to describe the relationship between input and output variables. Thirty batches of product were randomly manufactured according to the CCD and analysed to establish the stability in respect of viscosity, pH and the amount of FCV remaining following storage and the data were fitted to models using Design-Expert® software. A correlation between input variables and the responses was best described by a quadratic polynomial model. Analysis of Variance indicated that the response surface models were significant (P-value < 0.0001). The pH to which a FCV formulation was buffered was the most significant factor to effect the % drug content and the ultimate pH of the formulation, while the % w/v HPMC had the most significant effect on the viscosity of the product. The optimum composition for the manufacture of an oral liquid FCV formulation was predicted using the optimisation function of the Design-Expert® software. A low % error of prediction was established, indicating that the model is robust and that RSM is an appropriate formulation optimisation tool as it has a high prognostic ability. A liquid FCV formulation was developed, optimised and found to be suitable for its intended purpose. However further optimisation is required in respect of colourants, sweeteners and/or flavourants. The approach followed is useful in ensuring the development of quality products and can be applied in future.

No description available.

L’impact biologique exact des acides gras trans (TFA) sur la santé globale n’est toujours pas clair. Actuellement, il y a deux sources principales de TFA : 1- ceux qui se produisent naturellement dans les produits laitiers et de viande à la suite de la biohydrogénation chez les ruminants (R-TFA) et 2-ceux formés par des procédés industriels (I-TFA). Les I-TFA ont des effets néfastes sur le risque cardiovasculaire (CV), la résistance à l’insuline et le diabète de type 2. Cependant, les résultats actuels suggèrent que les R-TFA peuvent avoir des effets bénéfiques sur les facteurs de risque du diabète. À ce jour, peu d’études animales ont été menées à l’aide de R-TFA. Ces études suggèrent des mécanismes d’action potentiels qui peuvent expliquer les effets de la R-TFA sur le diabète de type 2 : diminution de l’inflammation, modification des niveaux d’expression génique et diminution de la graisse hépatique. L’objectif de cette étude était de développer une formulation qui pourrait encapsuler des R-TFA de manière isolée sans les autres constituants du lait. Pour ce faire, une stratégie de formulation visant à obtenir des solutions de TFA stables, solubles dans l’eau et biodisponibles ont été développées. Dans un premier temps, nous avons développé des formulations encapsulant les TFA dans des nanovésicules de 100 nm en moyenne. Nos résultats démontrent que ces formulations sont stables physiquement et chimiquement pendant une semaine. Dans un deuxième temps, nous avons administré ces formulations contenant les TFA aux animaux, par gavage. Les résultats obtenus démontrent que nos formulations assurent la biodisponibilité des TFA, sans moduler les concentrations plasmatiques d’autres acides gras. Enfin, nous avons démontré la versatilité de cette technique en coencapsulant des TFA avec d’autres molécules hydrophiles et hydrophobes telles que la vitamine D3 et la L-leucine. Ces résultats démontrent l’intérêt de l’utilisation de nanovésicules en sciences des aliments pour l’encapsulation de composés non solubles dans l’eau. In fine, ces formulations représentent une base solide pour mener à bien les études in vivo futures et comprendre les effets réels des R-TFA sur le DT2 et ses facteurs de risques.

No description available.

Tout épithélium glandulaire sécrétoire est constitué d'une unité structurale et fonctionnelle commune, l'acinus. C'est une architecture sphérique pluricellulaire parfaitement différentiée et polarisée qui, reconstruite en culture 3D, mime l'organisation réelle du tissu. Etudier les déterminants environnementaux et génétiques qui gouvernent la transformation d'un acinus en sphéroïde s'apparentant à une tumeur est l'un des enjeux majeurs des modèles in vitro. Un des défis actuels est d'adapter ces modèles in vitro à des conditions de culture 3D qui soient compatibles avec la réalisation de cribles génétiques en 3D, basés par exemple sur l'ARN interférence (RNAi). Cependant, les formats standards de culture 3D et les méthodes analytiques ne sont pas compatibles aux cribles haut-débit. Ils ne permettent pas de contrôler la taille et la distribution des acini, sont dépendants d'immuno-marquages et les acquisitions sont longues. Par ailleurs, la microscopie confocale et vidéomicroscopie offrent un champ d'observation restreint qui ne permet pas d'observer un grand nombre de structures 3D en même temps, pour permettre une analyse statistique. Ainsi, dans le but i) de développer des modèles cellulaires appropriés en 3D, ii) d'adresser des questions fondamentales relatives au cancer de la prostate et iii) de réaliser des cribles RNAi dans un contexte plus pertinent que la culture 2D, j'ai développé des outils innovants au format microsystèmes adaptés à l'analyse haut-débit d'un grand nombre d'objets 3D. En optimisant les conditions de culture cellulaire 3D sur le modèle de la lignée cellulaire RWPE1, j'ai pu récapituler les étapes de formation des acini prostatiques et montrer que la formation du lumen est indépendante de la polarité et est gouvernée par deux mécanismes, « hollowing » et cavitation. / In all secretory epithelia from glandular tissues, there is a common structural and functional unit, the acinus. It is a well polarized and organized pluricellular structure that is spontaneously reconstructed in 3D culture, therefore closely mimics the real structure we find in vivo. For my purpose, acini are used as models for tumor initiation and cancer development. One of the objectives of Biomics laboratory is to identify the genetic and microenvironmental determinants of prostate acini morphogenesis and polarity. The strategy is based on High-Throughput (HT) RNA interference (RNAi)-based screening. To meet this objective, my project was to develop appropriate 3D cell models which closely mimic the cyst-like and duct-like structure of prostate. By optimizing conventional 3D culture in Matrigel, I could recapitulate prostate acini morphogenesis and showed that lumen formation is independent to the polarity, which appears later. However, the conventional 3D cell culture formats and analytical tools are not suited for HT Screening (HTS). They lack control over acini size, are label-dependant and therefore time-consuming and labor intensive. Also, classical microscopy offers a very limited field of view and hence does not allow observing a large amount of 3D structures for statistical analysis.

L’encapsulation des espèces chargées ou neutres dans la cavité interne d’hôtes organiques est un domaine fascinant de la recherche et représente un défi pour de nombreux laboratoires partout dans le monde. La réussite exceptionnelle de ce sujet provient principalement de l’imagination des chimistes dans la conception et la synthèse d’hôtes organiques ayant une fonction de reconnaissance. Depuis l’origine du concept de la chimie hôte-invité, une grande variété de composés organiques a été synthétisée comme récepteurs moléculaires pouvant former des systèmes auto-organisés avec différents degrés de complexité. Les applications possibles sont la reconnaissance moléculaire, la vectorisation de médicaments, la séparation et le stockage, les biocapteurs et la catalyse (réaction chimique dans l’espace clos d’un nano-réacteur).L’objet de nos travaux consistait en la synthèse de molécules cages par auto-assemblage de cyclotrivératrylènes spécifiquement fonctionnalisés. De nombreux essais ont été menés pour dimériser deux CTV dans l’optique d’obtenir des cryptophanes auto-assemblés selon différents modes de coordination. Tout d’abord, des cyclotrivératrylènes fonctionnalisés par des pyridines ont été formés dans l’optique d’obtenir des cryptophanes auto-assemblés par des liaisons de coordination ou par des liaisons hydrogènes.Un second volet de nos travaux a été la synthèse de plusieurs cyclotrivératrylènes incorporant des atomes de soufre directement liés au cycle benzénique. Dans ce manuscrit figurent plusieurs voies synthétiques pour la synthèse du cyclotrithioguaiacylène ainsi que pour la formation du cyclotrithiophénolène. Des essais de dimérisation ont été menés et ont conduit contre toute attente à la formation d’un macrocycle incorporant huit unités cyclotrivératrylèniques. Ce dernier a pu être caractérisé par spectroscopie de RMN 1H et spectrométrie de masse MALDI-TOF / The encapsulation of charged or neutral species in the internal cavity of organic hosts is a fascinating area of research and a challenge for many laboratories around the world. The outstanding success of this subject comes mainly from the imagination of chemists in the design and synthesis of organic hosts with a recognition function. Since the origin of the concept of host-guest chemistry, a wide variety of organic compounds were synthesized as molecular receptors that can form self-organized systems with different degrees of complexity. Possible applications include molecular recognition, drug delivery, separation and storage, biosensors and catalysis (chemical reaction) in the confined space of a nano-reactorThe purpose of our work involved the synthesis of cage molecules by self-assembly of specifically functionalized cyclotrivératrylènes. Numerous tests were conducted to dimerize two CTV with a view to obtaining cryptophanes self-assembled according to different modes of coordination. First of all cyclotrivératrylènes functionalized with pyridines were formed with the aim of obtaining cryptophanes self-assembled by coordination bonds or hydrogen bonds. A second part of our work was the synthesis of several cyclotrivératrylènes incorporating sulfur atoms directly attached to the benzene ring. In this manuscript are presented several synthetic routes for the synthesis of cyclotrithioguaiacylene and cyclotrithiophenolene.Tests of dimerization were conducted and led against all odds to the formation of a macrocycle incorporating eight CTV units. The latter has been characterized by 1H NMR spectroscopy and MALDI-TOF mass spectrometry

Polyelectrolyte multilayer capsules fabricated by layer-by-layer (LbL) self-assembly technique consistsing of core-shell structure have emerged as potential drug delivery systems along with their applications in micro-reactors, cosmetics, vaccines and antimicrobial coatings. Various ligands and stimuli responsive entities can be incorporated into the core and shell of the capsules for targeted delivery and/or controlled release applications. Though multilayer capsules have been studied extensively as delivery systems, their utility for encapsulation of hydrophobic drugs and multiple drugs have not been explored in detail so far. Application of traditional polyelectrolyte capsules has several limitations, which renders them inapplicable for encapsulation of multiple drugs, hydrophobic drugs and also for releasing drugs on demand without addition of the external photothermal agents such as metal nanoparticles into the shells of the capsules. Thus, in this thesis, an attempt has been made to develop novel multifunctional multilayered capsules to overcome the above mentioned limitations. We have formulated two novel methods to functionalize the core with cyclodextrin molecules and the shell of the capsules with two-dimensional material, graphene oxide (GO). The properties such as high surface area along with π bonds, broad NIR-absorption, superior photothermal conversion and antimicrobial activity of graphene oxide has been explored and it has been demonstrated that 2-D graphene oxide is unique compared to the regular polyelectrolytes. By functionalizing the shell of capsules with GO as one of the layer material, a simple and efficient way for encapsulating multiple drugs into core and shell of the capsules is achieved by utilizing the large surface area and amphiphilic nature of GO. Based on the unique optical absorption and photothermal conversion properties of GO, we have demonstrated a facile route for near-infrared (NIR)-laser triggered release with low laser power. In the second part, functionalization of the hollow core of the capsules has been functionalized using cylodextrin (CD)-incorporated CaCO3 porous sacrificial templates, where both CD-CaCO3 and CD-modified capsules are used as high efficient carriers for hydrophobic drugs. In the third part, synergistic antimicrobial therapy was achieved using composite graphene oxide/polymer LbL films by combining the intrinsic antimicrobial activity and photothermal conversion ability of graphene oxide and the results depicted superior antimicrobial activity towards E. coli. These composite films also can be used as efficient antimicrobial coatings on biomedical devices or implants. The thesis has been divided into five chapters based on the individual works. In Chapter 1, a brief review on the history of LbL self-assembly, mechanism of self-assembly along with factors affecting the process have been discussed. Followed by a brief discussion about the fabrication of multilayered hollow capsules (core-shell structure), their applications in drug delivery and fabrication of multifunctional multilayered capsules through core and shell have been discussed. Finally, recent developments in LbL self-assembly and multilayered hollow capsules using carbon based materials (fullerenes, carbon nanotubes and graphene oxide) and their biomedical applications have been presented. Chapter 2 deals with the study on fabricating multifunctional multilayered capsules for facile encapsulation of multiple drugs into the capsules, which is achieved by functionalizing the capsules with graphene oxide (GO) as one of the layer materials. The GO composite capsules exhibited unique permeability properties compared to traditional multilayered capsules made of two polyelectrolytes. Multiple drugs could be simultaneously encapsulated in the capsules in a simple and effective manner. These capsules were found to exhibit a “core-shell” loading property for encapsulation of dual drugs into the core and shell of the capsules respectively. In addition, the graphene oxide composite capsules showed excellent biocompatibility towards MCF-7 cells. This study is the first one that demonstrates the potential of hybrid polyelectrolyte capsules without the use of micelles or polymer-drug conjugates for multi-drug encapsulation. Chapter 3 deals with the development of a facile route for near-infrared (NIR)-light triggered release of encapsulated drugs from the multilayered capsules via incorporation of graphene oxide (GO) into layer-by-layer (LbL) assembled capsules without addition of any external additives such as metal nanoparticles (NPs) or carbon nanotubes (CNTs) into the shells of the capsules. Till now, there is no report on light-responsive drug delivery system by utilizing the NIR-optical absorption properties of GO. Here, graphene oxide (GO) plays a dual role, serving as a structural component of LbL capsules as well as strong NIR-light absorbing agent, which efficiently converts absorbed light into heat. Upon NIR-laser irradiation, the microcapsules were opened in “point-wise fashion” due to local heating caused by laser irradiation. The rupturing mechanism of the capsules has been clearly demonstrated using confocal fluorescence microscopy and high resolution transmission electron microscopy. The light-triggering ability of these capsules has been applied successfully to release the encapsulated anticancer drug, doxorubicin. Chapter 4 deals with simple and versatile simple routes for encapsulation of model hydrophobic drug. Encapsulation of hydrophobic drugs in pharmaceutical industries is always a big challenge due to limited number of available drug carrier systems and poor aqueous solubility of hydrophobic drugs. Here, by combining the special properties of cyclodextrins (CDs) with biodegradable inorganic calcium carbonate microparticles, the hybrid CD-CaCO3 mesoporous microparticles have been prepared for the first time. These CD-CaCO3 microparticles were utilized as sacrificial templates to prepare CDs-modified LbL capsules. We have demonstrated that both the hybrid CD-CaCO3 microparticles and CDs-modified capsules are potential carriers for encapsulation of model hydrophobic drugs (self-fluorescent coumarine and nile red dyes) with high loading efficiency using supramolecular host-guest interaction between entrapped CDs and hydrophobic dye molecules. Compared with other inorganic drug carrier systems (mesoporous silica), CaCO3 porous particles have better biocompatibility, biodegradability and cost-effective and without use of any organic solvents. Both these hybrid CD-CaCO3 microparticles and CDs-modified capsules can be good candidates for encapsulation of hydrophobic drugs without involving extreme chemical conditions for fabrication. Chapter 5 deals with development of facile synergistic method for killing pathogenic bacteria by combining the intrinsic antimicrobial activity of graphene oxide (GO) and unique photothermal conversion property of GO into a single material. We fabricated composite LbL films of graphene oxide (GO) and poly(allylamine hydrochloride) (PAH) films. Antimicrobial activity of these GO composite films has been studied using Escherichia coli (E. coli) cells by varying number of deposited layers on glass slides (20 to 80 layers) and results suggest that by increasing the number of deposited layers, antimicrobial activity is also increased gradually. Based on the unique optical properties of GO, photothermal therapy have been carried out for killing of E. coli using GO composite films by varying number of deposited layers (20 to 80 layers) by irradiation of NIR-pulse laser at 1064 nm wavelength (Nd:YAG, 10 ns pulse, 10 Hz). The photothermal results revealed the enhanced antimicrobial activity compared to GO composite films alone without NIR-laser irradiation. The synergistic photothermal killing ability along with intrinsic antimicrobial activity of GO films results in much faster killing compared to films alone.

Inledning: Sjuka barn behöver anpassad vård och säkra, effektiva och väldokumenterade läkemedel. Förskrivning och uttag av preparat för pediatriska populationen ökar, men en tydlig uppskattning på problematik finns inte. Problem kan uppstå, när en lämplig beredning saknas, när redan registrerade läkemedel saknar avdelade doser för barn eller är tillgängliga enbart som en tablett med vuxen dos. Varje barn sägs vara en individ med unika läkemedelsomsättning, metabolism och biverkningspanorama, vilket komplicerar behandling. Lösningen på detta är i många fall ett extemporeläkemedel eller ett licenspreparat, men långa ledtider och dålig tillgänglighet kan medföra svårigheter att kunna ge rätt terapi. Syftet med denna studie är att i) kartlägga behov och befintliga lösningar, ii) testa handhållna pulverdispenser (HPD) Quantos, som en lämplig metod för fasta beredningar för att tillhandahålla individuella läkemedelsdoser till barn i de fall godkända läkemedel inte räcker.  Metod: Databassökning, intervjuer av hälso-sjukvårdspersonal, samt laborativt arbete för att omformulera registrerade läkemedel i tablettformer till individanpassade doser i hårdgelatin-kapslar med hjälp av Mettler-Toledos handhållna pulverdoseringsinstrument HPD Quantos. Resultat: Litteraturstudien och intervjuer överensstämmer med varandra: behov av barnanpassade läkemedel finns. HPD Quantos kan vara en alternativ metod för fasta beredningar för att tillhandahålla mängderför uppdosering med en femte- och/ eller en sjättedel av en tablett. Slutsats: För att ombesörja behoven för barnanpassade doser på ett sjukhus, måste HPD Quantos automatiseras till en inbyggd doseringsstation. Detta kommer att säkerställa dosering, dölja obehaglig smak, samt minska arbetsmiljörisken vid exponering av toxiska läkemedel.

La construction des routes avec des techniques d'enrobage à chaud (T=160 °C) implique une consommation d'énergie fossile et des rejets de gaz à effet de serre importants. Une production plus écologique du bitume nécessite de diminuer les températures d'enrobage en conservant les propriétés mécaniques des enrobés ainsi obtenus. Le développement de techniques permettant de réduire les températures est donc un enjeu majeur de l'industrie routière. Dans ce travail, nous avons joué à la fois sur la composition et le procédé pour moduler les propriétés du bitume et atteindre l’objectif fixé.Nous avons décomposé le bitume en ses différentes fractions en utilisant des techniques de séparation asphaltènes/maltènes à l'aide d'un alcane (pentane et heptane). Nous avons formulé des bitumes à différentes proportions et natures d'asphaltènes en introduisant des protocoles de préparation originaux. A l’aide de techniques de caractérisation variées telles que la rhéologie, la diffusion des rayons X ou encore des techniques de microscopies et d'analyses thermiques, nous avons déterminéles rôles des différentes fractions du bitume. Nous avons ainsi montré l'impact important des asphaltènes, mais également des fractions que nous avons qualifiées « d'intermédiaires », sur les comportements rhéologiques. Enfin, nous avons élaboré des objets coeur-écorce, composés d’une écorce rigide, non collante, riche en asphaltènes et d’un coeur mou, riche en maltènes. Ces objets sont particulièrement intéressants pour le transport du bitume à température ambiante. / The classic manufacture of hot mix asphalt for road construction is associated with a high consumption of fossil fuels and a high level of emissions of greenhouse gases into the atmosphere. A cleaner production of bitumen requires lowering the manufacturing temperature of these products without impoverishing their level of mechanical performances. The development of technologies that enable temperature reduction had thus become a major objective in the field of road engineering. In this work, we are playing on both composition and process in order to control the final properties of the material and propose an interesting way to reduce temperature during transportation. We have been interested in the different fractions composing the bitumen. We have there by employed a separation technique with alkane (heptane and pentane) to segregate the maltenes and asphaltenes. We could therefore realize diverse reconstituted bitumen using original protocols. Using various characterization techniques (such as rheology, X-ray scattering, optic, electronic and atomic force microscopy, infrared spectroscopy, thermal analysis...), we get insight into the effect of asphaltenes content and nature on bitumen properties. Our results show the huge impact of asphaltenes and other fractions called "intermediate fractions" on bitumen rheological properties. Finally, we propose an innovative processing of bitumen via the elaboration of core/shell objects composed of a rigid, nonsticky and asphaltenes-rich corona and a soft maltenes-rich core. These objects are very interesting for transporting bitumen at ambient temperature.

Hard capsules filling machines are useful for some reasons: with them we can quick pack small quantities of powder, can make drugs for clinical trials, also can use them for students learning in university. But in literature we couldn’t find method how to count the right quantity of powder, need to fill in one capsule. For this reason, we perform some experimental works with acetylsalicylic acid, paracetamol and lactose to find out how it does right. During these works, we research how affect powder flow, powders moisture, filling condition, powder particle size to the capsules filling. Also we research is any differences between capsules position in capsules filling machine and its weight. To find is our method right, we made 3 series of acetylsalicylic acid capsules and made uniformity of content and uniformity of mass tests with them. Made accomplished fulfils European pharmacopeia’s demands.